Oropharynx (OPX) Biomarker Trial

Abroad (travel likely)Recruiting

Conditions

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Metastatic Oropharyngeal Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma · Recurrent Oropharyngeal Squamous Cell Carcinoma · Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Head and Neck Carcinoma · Head and Neck Neoplasm · Salivary Gland Neoplasms · Thyroid Gland Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Study coordinator (Diane Vogen) · Vogen.Diane2@mayo.edu · 507-266-1247
Contact: Principal Investigator (Kathryn M. Van Abel, MD)

Study leads

Kathryn M. Van Abel, MD
Principal Investigator
Mayo Clinic in Rochester

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Little Rock, United States

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Peoria, United States

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Atlanta, United States

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Carcinoma of Unknown Primary

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States